PATENT CLAIM ANALYSIS

Application Number: 15766215
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "093400"]

Abstract:
The invention relates to use of  Akkermansia muciniphila,  a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.

Claim (Index 25):
The method of  claim 21 , wherein said one or more  Akkermansia muciniphila  strains are administered to a subject identified as having a lower than normal level of  Akkermansia muciniphila  in the gastrointestinal tract.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15946031', '15139097', '15271672', '14952895', '15624372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6665408014551948
- 35 USC 102 Novelty (BERT): 0.5206202452676935
- Combined Prediction Score: 0.6519487458364447
- Mean Citation Score: 254.08586200000005
- Max Citation Score: 274.72498
- Similarity Product: 180.4524754702139

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test